Jegbefumen Glory Oziebge
Ambrose Alli University, Nigeria
This work was instigated by a certain comparative study drawn on immunogenic biological therapy and its clinical relevance on Psoriatic Arthritis delivered in a conference in 2016. The work which projected a comparative biological understudy of anti-inflammatory biologic activities as a catalysis on significant determinant in addressing diseases life activities in Psoriatic arthritis (PsA) especially, emphatic in the cases of joint infection, held that the residues of protein presences in biologics pre-disposes the capacities to re-create anti-drug antibodies (ADAbs) which may stimulate clinical investigation result. However, a critique look on the disparity of levels and frequencies of occurrences of ADAb formations, potentiate effects on safety and efficacy of texts, journals and articles sighted, theirs and others demonstrated a different level of result and outcome throwing up reason for further questions.